Medipol University has been conducting an important study to evaluate therapeutic methods aimed at improving lower extremity functionalities in individuals with chronic stroke. This clinical trial, currently listed as active but not recruiting, focuses on interventions that could enhance mobility and quality of life for patients facing long-term post-stroke challenges.
In this article:
- What is the study examining?
- What interventions are included?
- Who might benefit from the findings?
- Frequently Asked Questions
- Conclusion
- Disclaimer
What is the study examining?
The trial aims to address the gaps in mobility and balance faced by individuals suffering from chronic stroke. Researchers are targeting specific issues in lower extremity performance, such as knee joint proprioception, utilizing innovative therapeutic modalities. By focusing on a patient-centric approach, the trial seeks to determine how different intervention strategies might contribute to an improved rehabilitation process.
What interventions are included?
The clinical trial employs a wide range of assessment tools and therapeutic methods. Key interventions being evaluated include:
- Measurement of Knee Joint Position Sense: This method assesses proprioceptive accuracy.
- Berg Balance Scale (BDS): A tool to evaluate static and dynamic balance.
- Timed Up and Go Test (TUG): A simple test to examine mobility efficiency.
- 10-Meter Walking Test: Measures walking speed and endurance.
- Stroke-Specific Quality of Life Scale: Evaluates the overall impact of interventions on patient well-being.
Therapeutic techniques under analysis include closed kinetic chain exercises and the application of kinesiotape, with Physiomaster serving as an instrumental rehabilitation tool. These methods aim to provide measurable outcomes regarding functionality, mobility, and overall quality of life improvements.
Who might benefit from the findings?
This study primarily focuses on adult patients who live with the long-term effects of chronic stroke. By identifying effective strategies that target lower extremity weaknesses, the research findings could redefine rehabilitation practices and inform clinical guidelines. Healthcare providers, caregivers, and rehabilitation therapists stand to gain valuable insights into evidence-based interventions they can integrate into care plans.
Frequently Asked Questions
- What is the trial’s current status?
The trial is active but currently not recruiting participants. - Who is sponsoring the trial?
The study is sponsored by Medipol University. - What is the study’s main objective?
The goal is to evaluate various therapeutic methods aimed at improving lower extremity functions and overall quality of life in individuals with chronic stroke.
Conclusion
This clinical trial marks an important step forward in stroke rehabilitation research. By studying the effects of targeted therapies and practical interventions, Medipol University aims to enhance the standard of care for individuals living with chronic stroke. The outcomes could potentially transform how mobility and balance problems are managed, offering new hope for improved quality of life.
Disclaimer
This article is intended for informational purposes only and does not constitute legal or clinical advice. Always consult with qualified professionals for guidance specific to your practice or condition.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07258342?term=medical+device